Related Experiment Video
Updated: Feb 22, 2026
14:54
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
Published on: October 20, 2018
9.0K
SOME ADDITIONAL THOUGHTS ON FORTHCOMING AMENDMENTS TO HTA IN POLAND
1Agency for Health Technology Assessment & Tariff System,Warsaw,Poland.
International Journal of Technology Assessment in Health Care
|September 21, 2017
Summary
Poland
Area of Science:
- Health economics
- Healthcare policy
- Medical device regulation
Background:
- Recent reforms in Polish healthcare reimbursement policies.
- Potential impact on the utilization of health technology assessments (HTAs).
Purpose of the Study:
- To provide commentary on evolving reimbursement policies in Poland.
- To discuss the anticipated increase in health technology assessments (HTAs) for medical devices (MDs).
Main Methods:
- Analysis of current Polish healthcare reimbursement policy changes.
- Review of trends in health technology assessment adoption for medical devices.
Main Results:
- Reimbursement policy shifts are expected to drive a higher demand for HTAs.
- Increased scrutiny of medical devices within the Polish healthcare system is probable.
Conclusions:
- The evolving reimbursement landscape in Poland necessitates a greater focus on health technology assessment.
- Stakeholders should prepare for an increased volume of HTA submissions for medical devices.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
01:28Drug Products: Biologics, Biosimilars and Interchangeables
298
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
298
01:19Standards of Care II
1.1K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K
01:26FDA Approved Drugs: Changes to Approved Drugs
289
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
289
01:30Health Information Technology and Healthcare Information System
3.5K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.5K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
30
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
30